Migratory pulmonary infiltrates

Respiratory Medicine

Volumn 92, Issue 8, 1998, Pages 1081-1084

  Rodriguez, M C ^a   Capurro, M ^a   Gomez, F ^a   Ludena M D ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL;

AGED; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CASE REPORT; FEMALE; HUMAN; LUNG INFILTRATE; PRIORITY JOURNAL;

EID: 0031694802     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90360-2     Document Type: Article

References (11)

1. Miyagawa Y, Nagata N, Shigematsu N. Clinicopathological study of migratory lung infiltrates. Thorax 1991; 46: 233-238.
2. Bayle SY, Nesme P, Béjui-Thivolet F, Loire R, Guerin JC, Cordier JF. Migratory organizing pneumonitis 'primed' by radiation therapy. Eur Respir J 1995; 8: 322-326.
3. Crestani B, Kambouchner M, Soler P et al. Migratory bronchiolitis obliterans-organizing pneumonia after unilateral radiation therapy for breast carcinoma. Eur Respir J 1995; 8: 318-321.
4. Cherniack RM, Abrams J, Kalica AR. Pulmonary disease associated with breast cancer therapy. Am J Respir Crit Care Med 1994; 150: 1169-1173.
5. Todd NW, Peters WP, Ost AH, Roggli VL, Piantadosi CA. Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1264-1270.
6. Gould VE, Miller J. Sclerosing alveolitis induced by cyclophosphamide; ultrastructural observations on alveolar injury and repair. Am J Pathol 1975; 81: 513-530.
7. Morse CC, Sigler C, Lock S, Hakkinen PJ, Haschek WM, Witschi HP. Pulmonary toxicity of cyclophosphamide: a 1-year study. Exp Mol Pathol 1985; 45: 251-260.
8. Cooper JAD, Merrill WW, Reynolds HY. Cyclophosphamide modulation of bronchoalveolar cellular populations and macrophage oxidative metabolism: possible mechanisms of pulmonary pharmacotoxicity. Am Rev Resp Dis 1986; 134: 108-114.
9. King TE. BOOP: an important cause of migratory pulmonary infiltrates? Eur Respir J 1995; 8: 193-195.
10. Muller NL, Staples CA, Miller RR, Vedal S, Thurlbeck WM, Ostrow DN. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 1987; 165: 731-734.
11. De Castro J, Vilches Y, Gonzalez M. Toxicidad pulmonar del tratamiento del cancer. Med Clin (Barc) 1995; 105: 661-668.